Immutep IMMP
NASDAQ IMMP
$4.71 -0.17 (-3.48%)
At close: Sep 29, 2026 · 4:00 PM EDT

Immutep (IMMP) Restructuring Costs (2018 - 2019)

Updated

Immutep (IMMP) posted Restructuring Costs of $165,933 for the quarter ended Jun 30, 2019, down 55.6% from $373,588 a year earlier.

Analysis

Immutep (IMMP) Restructuring Costs (2018 - 2019) Analysis & Trends

  • In prior years, Immutep's Restructuring Costs was $382,660 in the year ended Jun 30, 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Immutep 35.63 Mn 35.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 165,932.78
Jun 30, 2018 373,587.88
API Access

Immutep Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=IMMP&period=max&api_key=YOUR_API_KEY